EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression

Juan Manuel Velázquez-Enríquez iD, Alma Aurora Ramírez-Hernández, Jovito César Santos-Álvarez, Edilburga Reyes-Jiménez iD, Antonio Arcos-Román, Jaime Arellanes-Robledo iD, Carlos Alberto Matias-Cervantes iD, María Del Socorro Pina-Canseco iD, Verónica Rocío Vásquez-Garzón, Rafael Baltiérrez-Hoyos iD

Advances in Respiratory Medicine · 2026

DOI: 10.3390/arm94050060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Respiratory Medicine, 2026. Verfasst von Juan Manuel Velázquez-Enríquez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Biomedicina Traslacional y Sistemas, Centro de Investigación en Nutrición y Alimentación, Universidad del Istmo, Carretera Transísmica…. Hauptthemen laut MEDLINE: Chlorogenic Acid, Transforming Growth Factor beta1, Pulmonary Fibrosis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONAHCyT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease driven by aberrant extracellular matrix deposition, with the activity of transforming growth factor-beta 1 (TGF-β1) orchestrating fibrogenesis. Current therapies are limited by severe adverse effects, highlighting the unmet need for safer treatments. In this study, the therapeutic potential of chlorogenic acid (CGA) in a murine model of pulmonary fibrosis was evaluated.

Methods

Pathology was induced on day 0 via subcutaneous osmotic minipumps delivering bleomycin (BLM) for one week, followed by pump removal on day 10. Therapeutic interventions with intragastric CGA (60 mg/kg) were administered daily from days 14 to 20. Lung tissue samples obtained on day 21 were analyzed via histological, immunohistochemical, and RT–PCR methods.

Results

Histological analysis via H&E and Masson’s trichrome staining revealed that CGA treatment significantly attenuated alveolar thickening, restored the alveolar space, and reduced the total cell density and Ashcroft fibrosis score. Furthermore, CGA markedly decreased collagen deposition. Quantitative RT–PCR and immunohistochemical assays revealed that CGA effectively decreased the expression of Col1a1, TGF-β1, and the myofibroblast marker alpha-smooth muscle actin (α-SMA).

Conclusions

CGA exerts important therapeutic effects by decreasing the expression of TGF-β1 and the activation of myofibroblasts, indicating that this natural polyphenol is a promising candidate for mitigating the progression of pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlorogenic AcidTransforming Growth Factor beta1Pulmonary FibrosisAnimalsBleomycinMiceDisease Models, AnimalMaleMice, Inbred C57BLActins

Stichwörter der Autor:innen

TGF-β1bleomycinchlorogenic acidcollagenfibrosisinflammationpulmonary fibrosis

Substanzen

Chlorogenic AcidBleomycinTransforming Growth Factor beta1Actins

Autor:innen und Institutionen

  • Laboratorio de Biomedicina Traslacional y Sistemas, Centro de Investigación en Nutrición y Alimentación, Universidad del Istmo, Carretera Transísmica Juchitán, La Ventosa km. 14, La Ventosa C.P. 70102, Oaxaca, Mexico.
  • Laboratorio de Fibrosis y Cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Sur, San Felipe del Agua, Oaxaca de Juárez C.P. 68020, Oaxaca, Mexico.
  • Laboratorio de Diagnóstico Molecular, Facultad de Medicina, Universidad Autónoma de Guerrero, Avenida Solidaridad S/N Hornos Insurgentes, Acapulco C.P. 39300, Guerrero, Mexico.
  • Laboratorio de Enfermedades Hepáticas, Instituto Nacional de Medicina Genómica-INMEGEN, Mexico City C.P. 14610, Mexico.
  • Dirección Adjunta de Investigación Humanística y Científica, Consejo Nacional de Humanidades, Ciencias y Tecnologías-SECIHTI, Mexico City C.P. 03940, Mexico.
  • SECIHTI-Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Sur, San Felipe del Agua, Oaxaca C.P. 68020, Mexico.

ORCID-Profile: Juan Manuel Velázquez-Enríquez, Edilburga Reyes-Jiménez, Jaime Arellanes-Robledo, Carlos Alberto Matias-Cervantes, María Del Socorro Pina-Canseco, Rafael Baltiérrez-Hoyos

Förderung

  • CONAHCyT

Zitieren

APA

Velázquez-Enríquez, J. M., Ramírez-Hernández, A. A., Santos-Álvarez, J. C., Reyes-Jiménez, E., Arcos-Román, A., Arellanes-Robledo, J., Matias-Cervantes, C. A., Pina-Canseco, M. D. S., Vásquez-Garzón, V. R., & Baltiérrez-Hoyos, R. (2026). Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression. Advances in Respiratory Medicine. https://doi.org/10.3390/arm94050060

Vancouver

Velázquez-Enríquez JM, Ramírez-Hernández AA, Santos-Álvarez JC, Reyes-Jiménez E, Arcos-Román A, Arellanes-Robledo J, et al. Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression. Advances in Respiratory Medicine. 2026. doi:10.3390/arm94050060

BibTeX
@article{VelzquezEnrquez2026,
  author = {Velázquez-Enríquez, Juan Manuel and Ramírez-Hernández, Alma Aurora and Santos-Álvarez, Jovito César and Reyes-Jiménez, Edilburga and Arcos-Román, Antonio and Arellanes-Robledo, Jaime and Matias-Cervantes, Carlos Alberto and Pina-Canseco, María Del Socorro and Vásquez-Garzón, Verónica Rocío and Baltiérrez-Hoyos, Rafael},
  title = {Chlorogenic Acid Attenuates Bleomycin-Induced Pulmonary Fibrosis in a Murine Model by Modulating TGF-β1 Expression},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  doi = {10.3390/arm94050060}
}
Kostenlos starten →